{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:35:41Z","timestamp":1794548141338,"version":"4.9.1"},"reference-count":44,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Dasman Diabetes Institute and Kuwait Foundation for the Advancement of Sciences"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,10]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Obesity is a global public health issue, with its effects a particular issue in Kuwait. Advances in pharmaceutical treatment (eg, glucagon-like peptide-1s) offer an effective solution, with the magnitude of weight lost something to celebrate. However, this level of weight loss also results in dramatic reductions in lean mass, reflecting loss of muscle mass and muscle strength which can predispose people to sarcopenia. This is a particular issue in people with type 2 diabetes in Kuwait, where the prevalence of muscle weakness is extremely high. Solutions to mitigate this loss of muscle mass and strength are needed, with a pragmatic resistance exercise intervention and increasing dietary protein intake having potential. This trial aims to determine whether resistance exercise and\/or protein intake can preserve muscle mass and improve physical function in people with obesity initiating semaglutide\/tirzepatide therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This single-centre, 6-month, randomised controlled trial at Dasman Diabetes Institute will enrol 232 adults with obesity, randomised (1:1:1:1) to control, resistance exercise, protein supplementation or combined resistance exercise and protein in conjunction with semaglutide or tirzepatide therapy. Resistance exercise will be home-based and involve three sessions per week, progressing from one to three sets targeting major muscle groups. Protein supplementation will target 1.6 g\/kg\/day via dietary adjustment and protein products. Assessments at baseline and 6 months will include MRI measured quadriceps cross-sectional area (primary outcome), plus measures of secondary outcomes of MRI measured liver fat content and stiffness and intramuscular fat, body composition (dual energy X-ray absorptiometry), strength, physical function, dietary assessment, physical activity levels, sleep patterns, quality of life, glycaemic control and metabolic biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      The study has received ethical approval from the Dasman Diabetes Institute Ethical Review Committee (HR-RA-2025-01, 19 February 2025) and is registered at ClinicalTrials.gov (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06885736\">NCT06885736<\/jats:ext-link>\n                      , 26 June 2025). Written informed consent will be obtained from all participants, with no financial compensation provided. Data will be reported in accordance with Consolidated Standards of Reporting Trials (CONSORT) guidelines, ensuring participant anonymity. Findings will be disseminated through peer-reviewed publications and presentations at national and international conferences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06885736\">NCT06885736<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116911","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:30:23Z","timestamp":1776864623000},"page":"e116911","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06885736","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06885736","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06885736","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06885736","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-7319","authenticated-orcid":false,"given":"Ameenah A","family":"Alawadhi","sequence":"first","affiliation":[{"name":"Clinical Care Research and Trials, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dherar","family":"Alroudhan","sequence":"additional","affiliation":[{"name":"Education and Training Unit, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal J","family":"Alsaeed","sequence":"additional","affiliation":[{"name":"Clinical Care Research and Trials, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashayer W","family":"Almarshad","sequence":"additional","affiliation":[{"name":"Clinical Care Research and Trials, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal H","family":"Alshehabi","sequence":"additional","affiliation":[{"name":"Clinical Care Research and Trials, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreya A","family":"Allahou","sequence":"additional","affiliation":[{"name":"Nutrition Unit, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Mashankar","sequence":"additional","affiliation":[{"name":"Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebaa","family":"Al Ozairi","sequence":"additional","affiliation":[{"name":"Medical Division, Dasman Diabetes Institute, Kuwait City, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8969-9636","authenticated-orcid":false,"given":"Stuart","family":"Gray","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026042206301379000_16.4.e116911.1","unstructured":"World Health Organization . Obesity and Overweight. 2025. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"2026042206301379000_16.4.e116911.2","unstructured":"World Health Organization . Global health risks: mortality and burden of disease attributable to selected major risks. 2009."},{"key":"2026042206301379000_16.4.e116911.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.03.024"},{"key":"2026042206301379000_16.4.e116911.4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00449","article-title":"The Prevalence of Overweight and Obesity in an Adult Kuwaiti Population in 2014","volume":"10","author":"Weiderpass","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026042206301379000_16.4.e116911.5","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0033"},{"key":"2026042206301379000_16.4.e116911.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-1678"},{"key":"2026042206301379000_16.4.e116911.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-3"},{"key":"2026042206301379000_16.4.e116911.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"2026042206301379000_16.4.e116911.9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S2213-8587(19)30086-5","article-title":"Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Pollock","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026042206301379000_16.4.e116911.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32590-X"},{"key":"2026042206301379000_16.4.e116911.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038868"},{"key":"2026042206301379000_16.4.e116911.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107519"},{"key":"2026042206301379000_16.4.e116911.13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3803\/EnM.2019.34.3.247","article-title":"A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans","volume":"34","author":"Sargeant","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2026042206301379000_16.4.e116911.14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"key":"2026042206301379000_16.4.e116911.15","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2206038"},{"key":"2026042206301379000_16.4.e116911.16","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12411"},{"key":"2026042206301379000_16.4.e116911.17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcsm.12160","article-title":"Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function","volume":"8","author":"Dos Santos","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026042206301379000_16.4.e116911.18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.maturitas.2020.04.017","article-title":"Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: A prospective study from UK Biobank","volume":"138","author":"Petermann-Rocha","year":"2020","journal-title":"Maturitas"},{"key":"2026042206301379000_16.4.e116911.19","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116681"},{"key":"2026042206301379000_16.4.e116911.20","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/84.3.475"},{"key":"2026042206301379000_16.4.e116911.21","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1183"},{"key":"2026042206301379000_16.4.e116911.22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/dom.15338","article-title":"In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank","volume":"26","author":"Boonpor","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026042206301379000_16.4.e116911.23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1067227","article-title":"A comparison of physical activity, muscle strength, and sleep between people with type 2 diabetes in Kuwait and the UK: A cross-sectional study","volume":"13","author":"Al Ozairi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026042206301379000_16.4.e116911.24","doi-asserted-by":"publisher","DOI":"10.1249\/JSR.0b013e31825dabb8"},{"key":"2026042206301379000_16.4.e116911.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.576"},{"key":"2026042206301379000_16.4.e116911.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2024-002363","article-title":"Effect of resistance exercise on body composition, muscle strength and cardiometabolic health during dietary weight loss in people living with overweight or obesity: a systematic review and meta-analysis","volume":"11","author":"Binmahfoz","year":"2025","journal-title":"BMJ Open Sport Exerc Med"},{"key":"2026042206301379000_16.4.e116911.27","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2028198"},{"key":"2026042206301379000_16.4.e116911.28","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3677","article-title":"The effect of home-based resistance exercise training in people with type 2 diabetes: A randomized controlled trial","volume":"39","author":"Al Ozairi","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"2026042206301379000_16.4.e116911.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-025-00986-1","article-title":"The effects of a home-based resistance training programme on body composition and muscle function during weight loss in people living with overweight or obesity: a randomised controlled pilot trial","volume":"22","author":"Binmahfoz","year":"2025","journal-title":"Nutr Metab (Lond)"},{"key":"2026042206301379000_16.4.e116911.30","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-097608"},{"key":"2026042206301379000_16.4.e116911.31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11154-025-09947-8","article-title":"Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?","volume":"26","author":"Al-Awadi","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"2026042206301379000_16.4.e116911.32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1249\/MSS.0b013e3181b2ef8e","article-title":"Increased protein intake reduces lean body mass loss during weight loss in athletes","volume":"42","author":"Mettler","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"2026042206301379000_16.4.e116911.33","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13841","article-title":"Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity","volume":"26","author":"Mechanick","year":"2025","journal-title":"Obes Rev"},{"key":"2026042206301379000_16.4.e116911.34","doi-asserted-by":"crossref","DOI":"10.1177\/2050313X251388724","article-title":"Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1\/GIP receptor agonists: A case series","volume":"13","author":"Tinsley","year":"2025","journal-title":"SAGE Open Med Case Rep"},{"key":"2026042206301379000_16.4.e116911.35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/nu18010131","article-title":"Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review","volume":"18","author":"Barana","year":"2026","journal-title":"Nutrients"},{"key":"2026042206301379000_16.4.e116911.36","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12834"},{"key":"2026042206301379000_16.4.e116911.37","doi-asserted-by":"publisher","DOI":"10.1519\/R-17224.1"},{"key":"2026042206301379000_16.4.e116911.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-023-01775-6","article-title":"Relationship of liver fat content with systemic metabolism and chronic complications in patients with type 2 diabetes mellitus","volume":"22","author":"Ren","year":"2023","journal-title":"Lipids Health Dis"},{"key":"2026042206301379000_16.4.e116911.39","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.21037\/qims-20-989","article-title":"Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method","volume":"11","author":"Zhang","year":"2021","journal-title":"Quant Imaging Med Surg"},{"key":"2026042206301379000_16.4.e116911.40","doi-asserted-by":"crossref","first-page":"110260","DOI":"10.1016\/j.ejrad.2022.110260","article-title":"Comparison of muscle fat fraction measurements in the lower spine musculature with non-contrast-enhanced CT and different MR imaging sequences","volume":"150","author":"Trueb","year":"2022","journal-title":"Eur J Radiol"},{"key":"2026042206301379000_16.4.e116911.41","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121360"},{"key":"2026042206301379000_16.4.e116911.42","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s00261-020-02783-1","article-title":"Liver fat quantification: where do we stand?","volume":"45","author":"Starekova","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"2026042206301379000_16.4.e116911.43","doi-asserted-by":"crossref","DOI":"10.2196\/13591","article-title":"Web-Based Dietary Intake Estimation to Assess the Reproducibility and Relative Validity of the EatWellQ8 Food Frequency Questionnaire: Validation Study","volume":"5","author":"Alawadhi","year":"2021","journal-title":"JMIR Form Res"},{"key":"2026042206301379000_16.4.e116911.44","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:30:30Z","timestamp":1776864630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,22]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2026-116911"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116911","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116911.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}